Scotland · NHS Scotland MSAN
Disopyramide (Rythmodan®) 100mg capsules and disopyramide (Rythmodan
MSAN(2026)20 · Level 2 · issued 25 Jun 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Disopyramide (Rythmodan®) 100mg capsules will be in out of stock from late June 2026 | Out of stock | — |
| stock from late June until late July 2026 and can support a partial uplift in demand once | Available — partial uplift only | late July 2026 |
| in limited supply and cannot support an uplift in demand. | Limited supply | — |
| treatment for patients who do not have sufficient supply until stock is available in late July | Available | stock is available in late July |
| with the SPS website. Registration for access to the website is available to UK healthcare | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.